Councils - Pulmonary Hypertension

SCIENTIFIC COUNCIL ON PULMONARY HYPERTENSION
COUNCIL LEADERSHIPQUICK LINKS
CHAIRSUPCOMING EVENTS

PH Council Meeting (Grand Hall B)
Saturday, April 12, 2014
12:05 PM - 12:55 PM


PH Council Report to the Board (La Jolla AB)
Sunday, April 13, 2014
7:00 AM

Both events will take place at the Manchester Grand Hyatt Hotel
San Diego, CA, USA




PAST COUNCIL MEETING REPORT:

2013 PH Council Report to the Board (PDF)



LINKS NEWSLETTER

Issues focusing on Pulmonary Hypertension:

March 2014
October 2013
May 2013: PH Council Year in Review
July 2012
December 2011 (PDF)






CHAIR
Robert P. Frantz, MD
Mayo Clinic
Rochester, Minnesota, USA
507-284-0294
frantz.robert@mayo.edu

Robert P. Frantz, MD, FACC, is Director of the Pulmonary Hypertension Clinic at the Mayo Clinic in Rochester, Minnesota, and Associate Professor of Medicine at the College of Medicine, Mayo Clinic. Primary interests include pulmonary hypertension both WHO Group I, and also associated with left heart disease and in context of MCS and transplantation. He performs hemodynamic assessments including exercise and drug interventions in the catheterization laboratory for patients with PAH, left heart disease, and MCS. Clinical responsibilities include management of cardiac transplant candidates and recipients, PAH, advanced left heart disease, and MCS recipients. Dr. Frantz graduated cum laude (Biochemistry) from Harvard University, Cambridge MA. He received his medical degree from Mayo Medical School, Rochester MN and completed Internal Medicine residency at the Mayo Graduate School of Medicine. After completing fellowship in Cardiovascular Diseases at University of Rochester Medical Center, Strong Memorial Hospital, Rochester, NY, Dr. Frantz joined the staff of the Mayo Clinic in 1990. Dr. Frantz is board certified in cardiology and internal medicine.


VICE CHAIR
Mardi Gomberg-Maitland, MD, MSc
University of Chicago
Chicago, Illinois, USA
773-702-5589
mgomberg@medicine.bsd.uchicago.edu

Mardi Gomberg-Maitland, MD, MSc, is Associate Professor of Medicine and Director of the Pulmonary Hypertension Program at the University of Chicago Medical Center.  She is an expert clinician and researcher in the field of pulmonary heart disease. In recent years, she has participated in dozens of multi-center, multi-national research trials to explore new therapies for pulmonary hypertension. She is a former Doris Duke Clinical Scientist winner for her research in Phase I drug development. She is currently focusing on pulmonary arterial, pulmonary venous hypertension/diastolic dysfunction, and biomarker development. Dr. Gomberg-Maitland attended medical school at the Albert Einstein College of Medicine in New York. She completed her residency at the New York Presbyterian Hospital-Weill/Cornell Medical Center and a fellowship at Mount Sinai Medical Center in New York.  In addition, she has earned a Masters in Clinical Epidemiology from Harvard School of Public Health in Boston, Massachusetts. She is board certified in Internal Medicine and Cardiology.


PAST CHAIR
Myung H. Park, MD, FACC
University of Maryland School of Medicine
Baltimore, Maryland, USA
410-328-7260
mpark@medicine.umaryland.edu

Myung Park, MD, FACC, is Director of the Pulmonary Vascular Diseases Program & CCU, and Associate Professor of Medicine, at the University of Maryland Medical Center. After receiving her medical degree from the Temple University School of Medicine, Dr. Park continued her training in Philadelphia with an internship and residency in internal medicine at Temple University Hospital.This was followed by a fellowship in cardiovascular medicine at the Medical College of Virginia. She furthered her training by completing an advanced fellowship in Heart Failure and Cardiac Transplantation at the Cleveland Clinic Foundation. Dr. Park is board certified in cardiology and internal medicine. She specializes in pulmonary hypertension, heart transplantation, advanced heart failure, and ventricular assist devices.
COMMITTEE REPRESENTATIVES
2014 ANNUAL MEETING PROGRAM COMMITTEE
Prof Paul A. Corris
Freeman Hospital
Newcastle University & CT Centre
Newcastle Upon Tyne, UNITED KINGDOM
44-191-223-1084
paul.corris@ncl.ac.uk

Bio coming soon...




Marc de Perrot, MD, MSc
Toronto
General Hospital
Toronto, Ontario,
CANADA
416-340-5549
Marc.DePerrot@uhn.ca

Bio
coming soon....





Mandeep R. Mehra, MD, MBBS, FACC, FACP
Brigham & Women's Hospital
Boston, MA, USA
617-732-8535
mmehra@partners.org

Dr. Mehra, an internationally recognized cardiologist with expertise in the treatment of heart failure and heart muscle damage, cardiac transplantation and mechanical circulatory devices, is professor of Medicine at Harvard Medical School and Executive Director of the Center for Advanced Heart Disease at the Brigham and Women's Hospital in Boston, MA (USA). He obtained his cardiovascular training at the Ochsner Clinic Foundation, where he sub-specialized in the field of advanced heart failure and cardiac transplantation. He is board certified in internal medicine and cardiovascular diseases. His specific research interests in cardiac transplantation focus on post-transplant coronary arterial disease, new immunosuppressive therapy to improve heart transplant outcomes, and bringing genomic and proteomic science (the study of protein interactions in the body) to the bedside. In the field of heart failure, his research has focused on the role of new devices and novel serum markers to guide diagnosis and therapy.


Myung H. Park, MD
University of Maryland School of Medicine
Baltimore, MD, USA
410-328-7260
mpark@medicine.umaryland.edu

See 'Past Chair' for bio.




Fernando Torres, MD
UT Southwestern Medical Center
Dallas, Texas, USA
214-645-5989
fernando.torres@utsouthwestern.edu

Bio coming soon...
DEVELOPMENT COMMITTEE PH WORKFORCE LEADER
Evelyn Horn, MD
Weill Cornell Medical Center
New York, New York, USA
212-746-2381
horneve@med.cornell.edu

Dr. Evelyn Horn is the Director of Heart Failure and Pulmonary Hypertension at the Perkin Heart Failure Center of Weill Cornell, specializing in Heart Failure, Pulmonary Hypertension, and Mechanical Circulatory Support. She is a graduate of Brown University, Mount Sinai Medical School where she also was a medical intern and resident. She completed cardiology at the Cedars Sinai/UCLA program and thereafter spent 2 years as a research fellow at Columbia College of Physicians and Surgeons, understanding the beta adrenergic G protein complex in heart failure, the denervated heart and models of arrhythmias. She has received numerous awards as clinician educator and continues to participate in clinical research in the areas of cardiac and vascular remodeling in heart failure and pulmonary hypertension.
EDUCATION COMMITTEE PH WORKFORCE LEADER
Dana P. McGlothlin, MD
Kaiser San Francisco
San Francisco, California, USA
415-710-9935
Dana.p.McGlothlin@kp.org

Bio coming soon...
I2C2 COMMITTEE PH WORKFORCE LEADER
John Granton, MD
University of Toronto
Toronto, Ontario, CANADA
416-340-4485
john.granton@uhn.on.ca

Bio coming soon...
REGISTRIES & DATABASES COMMITTEE PH WORKFORCE LEADER
Ivan Robbins, MD
Vanderbilt University Medical Center
Nashville, Tennessee, USA
615-322-6512
ivan.robbins@vanderbilt.edu

Bio coming soon...
STANDARDS & GUIDELINES COMMITTEE PH WORKFORCE LEADER
Teresa De Marco, MD, FACC
University of California, San Francisco
San Francisco, California, USA
415-476-3117
demarco@medicine.ucsf.edu

Bio coming soon...Workforce Members: PDF

LIAISONS
BOARD OF DIRECTORS LIAISON
Myung H. Park, MD (2016)
University of Maryland School of Medicine
Baltimore, MD, USA
410-328-7260
mpark@medicine.umaryland.edu

See bio under "Past Chair".
BSTR COUNCIL LIAISON
James D West, PhD
Vanderbilt University Medical Center
Nashville, Tennessee, USA
615-343-0895
j.west@vanderbilt.edu

Dr. West’s research focuses on early molecular events in the etiology of heritable pulmonary arterial hypertension, and whether these events are applicable to the broader field of idiopathic pulmonary arterial hypertension. His work uses several transgenic and nontransgenic mouse models, cell culture, and patient samples. His group is currently studying the role of BMPR2 and CAV1 mutations in altering focal adhesions and cytoskeletal defects, intracellular trafficking (and steroid hormone trafficking in particular), metabolism and generation of reactive oxygen species, and interaction between pulmonary vascular cells and circulating inflammatory cells. Dr. West has also just assumed responsibility for the Pulmonary Hypertension Breakthrough Initiative lung collection at Vanderbilt.
COMMUNICATIONS LIAISON
Veronica Franco, MD
Ohio State University
Columbus, Ohio, USA
614-293-4967
veronica.franco@osumc.edu

Veronica Franco, MD, FACC, is director of the Exercise Physiology/Metabolic Exercise Testing Program and Head of Pulmonary Hypertension Research for the division of Cardiology. Her expertise is in pulmonary arterial hypertension, right ventricular failure, advanced heart failure, cardiac transplant, and mechanical support of the heart. She is an assistant professor of clinical medicine at The Ohio State University Medical Center. Dr. Franco earned her medical degree from the Universidad Peruana Cayetano Heredia in Lima, Peru. She completed her residency in internal medicine from the University of Alabama at Birmingham. She received her Cardiovascular Medicine Fellowship training at the University of Alabama at Birmingham with subspecialty training in Pulmonary vascular disease, Heart Failure and Cardiac Transplantation which was completed in 2007. Dr. Franco also obtained a Masters in Clinical Research and Statistics at the same institution's School of Public Health. Further, Dr. Franco completed a research fellowship in the Vascular Biology and Hypertension Program at the University of Alabama at Birmingham. Dr. Franco actively participates in clinical and research activities for patients with pulmonary hypertension and advanced heart failure. Dr. Franco's research interests are in right ventricular failure, pulmonary arterial hypertension and mechanical circulatory support of the heart using left ventricular assist devices (LVADs). She is also interested in investigating cardiopulmonary exercise testing in patients with right or left ventricular heart failure.
Text SizeIncrease Font SizeDecrease Font Size